Rare cancer

An un-dying mission
against cancer

In 2017, 1.7 million people in the US were diagnosed with cancer. At least 30 percent of those cancers were rare.
January 17th, 2018

What You Need To Know About SHEPHERD Therapeutics

There are many unusual things about Shepherd Therapeutics, but one of them is its origin. David Hysong, the company’s founder, is not your typical biotech founder...

Read More
January 2nd, 2018

Top 20 Life Science Startups to Watch in 2018

BioSpace is proud to present its NextGen Bio “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015. The NextGen Bio Class of 2018 is a stellar group of companies that are already making an enormous impact on the industry now and will into the future. Congratulations to this group!

Read More
October 5th, 2017
The Daily Free Press

Forbes new Discover Stage discusses future of medicine and healthcare

While science is constantly advancing, the field of medicine has been at a standstill, employing primitive practices that date back to the 1940s, according to David Fialkow, co-founder of venture capital firm General Catalyst.

Read more
April 10th, 2017
Tthread MB

How David Hysong And His Old Friend “Death” Are Working Together To Cure Rare Cancers

One of the realities of life that has always baffled me is the notion that one catastrophe in a person’s existence does not negate another from occurring. Somehow, it only seems fair and right that surviving an event that 'should have killed you' would be enough to earn you a “pass” from encountering any other that could do the same. Unfortunately, this ideal is far from the truth and no one knows this better than David Hysong, Founder and CEO Of Shepherd Therapeutics.

Read more
March 16th, 2017
Southern Living

This Kentucky Native Is Inspiring Cancer Patients Around The World

David Hysong could be called many things – survivor, motivator, educator – but 'victim' is certainly not one of them. This 29-year-old from Kentucky was recently named a Forbes 30 Under 30 in Healthcare for his dedication to fighting for the lives of rare cancer patients.

Read more
March 2nd, 2017
Business Insider

A 29-year-old founded a biotech startup to cure rare cancers after he got a life-changing diagnosis

David Hysong's life is like something out of a James Bond film.

The 29-year-old recent inductee to the Forbes 30 under 30 list for science has traveled the back roads of four different continents on his motorcycle. He's been hit by a bus going 60mph, and he spent some time in the streets of Cambodia fighting child slavery. At one point, he was even in the pipeline to become a US Navy Seal.

Read more
February 24th, 2017
BioSpace Life Sciences News

Future Biotech Giants: 11 Life Science Entrepreneurs Under 30

If there’s one reason to view biotech as the new center for the tech industry boom, it may be the number of 20-somethings founding biotech startups. Forbes came out with its Forbes 30 Under 30, looking at companies founded by 20-something entrepreneurs. Here’s a look at the top 11 who are involved in life science companies.

Read more
February 16th, 2017
Business news just got personal

David Hysong CEO and Founder, SHEPHERD Therapeutics

After being diagnosed with an ultra-rare form of head and neck cancer, David Hysong decided to develop a biotech company run by cancer patients for cancer patients. Since its birth in January of 2016, SHEPHERD Therapeutics has brought on talented scientists and pharmaceutical veterans with a mission to find cures for rare forms of cancer.

Read more
January 10th, 2017
Transylvania University

French major to biotech CEO David Hysong ’09

David Hysong ’09 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a cerebral MacGyver with entrepreneurial gifts, a strong faith and a desire to put himself on the line for others.

Read more
January 6th, 2017
St. John's College

Searching for a Cure

David Hysong has done a lot in his 29 years.

Student. Investigator. Coach. Entrepreneur.

Read more
January 3rd, 2017
Forbes

30 Under 30 Healthcare: The Researchers, Entrepreneurs And Policymakers Who Will Save Your Life

Our healthcare system is a mess. With a fresh outlook, the members of the Forbes 30 Under 30 in healthcare are looking to change it.

Read more
January 1st, 2017
30 Under 30 Healthcare

David Hysong Founder, Shepherd Therapeutics

By age 27, David Hysong had investigated the sexual enslavement of children in Cambodia and trained as a Navy SEAL. Then he found out he had a rare, untreatable, and lethal form of head-and-neck cancer.

Read more